Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Covetrus stock in Canada | $27.24

Own Covetrus shares in just a few minutes.


Fact checked

Covetrus, Inc is a health information services business based in the US. Covetrus shares (CVET.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $27.24 – an increase of 6.95% over the previous week. Covetrus employs 5,100 staff and has a trailing 12-month revenue of around $4.2 billion.

How to buy shares in Covetrus

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: CVET in this case.
  5. Research Covetrus shares. The platform should provide the latest information available.
  6. Buy your Covetrus shares. It's that simple.

How has Coronavirus impacted Covetrus's share price?

Since the stock market crash in March caused by coronavirus, Covetrus's share price has had significant positive movement.

Its last market close was $27.24, which is 55.95% up on its pre-crash value of $12 and 573.42% up on the lowest point reached during the March crash when the shares fell as low as $4.045.

If you had bought $1,000 worth of Covetrus shares at the start of February 2020, those shares would have been worth $485.34 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,132.35.

Covetrus share price

Use our graph to track the performance of CVET stocks over time.

Covetrus shares at a glance

Information last updated 2020-12-27.
Latest market close$27.24
52-week range$4.045 - $31.93
50-day moving average $27.272
200-day moving average $23.4149
Wall St. target price$24.75
PE ratio 40.8667
Dividend yield N/A (0%)
Earnings per share (TTM) $0.3

Compare online trading platforms

Name Product Available asset types Stock Fee Option Fee Account Fee ETF Transaction Cost
Wealthsimple Trade
Stocks, ETFs
Get a $25 bonus when you open a Wealthsimple Trade account and deposit and trade at least $100.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, IPOs, Precious Metals
$9.95 + $1 per contract
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Interactive Brokers
Stocks, Bonds, Options, Mutual Funds, ETFs, Currencies, Futures, Precious Metals
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0 (if monthly commissions are greater than or equal to US$10.00)
Min. $1.00, Max. 0.5% of trade value
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.

Compare up to 4 providers

Name Product Minimum deposit to invest Funding methods Management fee Available asset types
Wealthsimple Invest
Direct deposit, Bank transfer
0.40% - 0.50%
Stocks, Bonds, ETFs, Commodities
Get a $50 bonus when you open and fund your first Wealthsimple Invest account with a minimum initial deposit of at least $500. Trade and Cash accounts are not eligible.
CI Direct Investing (formerly WealthBar)
Direct deposit, Bank transfer
0.35% - 0.60%
Mutual Funds, ETFs
CI Direct Investing offers access to an exclusive and personalized investment portfolio. Get up to $10,000 managed free for a year when you sign up for your first CI Direct Investing account and fund your account.
Direct deposit, Bank transfer, Automatic bank withdrawals
Receive a cash bonus of $50.00-$225.00 when you open a new Justwealth account. RESP accounts require no minimum deposit to begin investing.
Automatic bank withdrawals
The Moka app rounds up every purchase you make to the nearest dollar and invests the spare change into low-cost exchange-traded funds (ETFs).

Compare up to 4 providers

Name Product Minimum Opening Deposit Commission Available Markets Platforms
Minimum US$25
Shares Desktop, Web Trading, Mobile Trading, MetaTrader 4
CFDs are leveraged products which involves greater risk than using cash resources only. You could lose all or more of your initial investment. Trade 80+ currency pairs and 220+ CFDs in equities, commodities and indices on

Compare up to 4 providers

Is it a good time to buy Covetrus stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Covetrus price performance over time

Historical closes compared with the last close of $27.24

1 week (2021-01-15) -26.14%
1 month (2020-12-23) -13.48%
3 months (2020-10-23) 0.89%
6 months (2020-07-23) 31.28%
1 year (2020-01-23) 84.30%

Is Covetrus under- or over-valued?

Valuing Covetrus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Covetrus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Covetrus's P/E ratio

Covetrus's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 41x. In other words, Covetrus shares trade at around 41x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Covetrus's PEG ratio

Covetrus's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6415. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Covetrus's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Covetrus's EBITDA

Covetrus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$105 million.

The EBITDA is a measure of a Covetrus's overall financial performance and is widely used to measure a its profitability.

Covetrus financials

Revenue TTM USD$4.2 billion
Gross profit TTM USD$749 million
Return on assets TTM -1.12%
Return on equity TTM -3.57%
Profit margin -1.23%
Book value $11.118
Market capitalisation USD$4.3 billion

TTM: trailing 12 months

How to short and sell Covetrus shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "CVET.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 6.5 million Covetrus shares held short by investors – that's known as Covetrus's "short interest". This figure is 5.1% down from 6.8 million last month.

There are a few different ways that this level of interest in shorting Covetrus shares can be evaluated.

Covetrus's "short interest ratio" (SIR)

Covetrus's "short interest ratio" (SIR) is the quantity of Covetrus shares currently shorted divided by the average quantity of Covetrus shares traded daily (recently around 826228.06122449). Covetrus's SIR currently stands at 7.84. In other words for every 100,000 Covetrus shares traded daily on the market, roughly 7840 shares are currently held short.

However Covetrus's short interest can also be evaluated against the total number of Covetrus shares, or, against the total number of tradable Covetrus shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Covetrus's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Covetrus shares in existence, roughly 50 shares are currently held short) or 0.0521% of the tradable shares (for every 100,000 tradable Covetrus shares, roughly 52 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Covetrus.

Find out more about how you can short Covetrus stock.

Covetrus share dividends

We're not expecting Covetrus to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Covetrus overview

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, and vitamins and supplements to wholesale and retail customers. The company also offers value-added practice solutions that include financial services, equipment repair, inventory management, and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as e-commerce, shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company, formerly known as HS Spinco, Inc., was incorporated in 2018 and is headquartered in Portland, Maine.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site